Rectal cancer · 5 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Capecitabine and RT Variant #01 | — | R 4 922 | 35d | — | — | 3 | R 8 817 PFS proxy | 1 |
FULV and RT Variant #04 | — | R 1 551 | 14d | — | — | ~5 | ~R 7 754 PFS proxy · indirect | 2 |
Fluorouracil and RT Variant #01 | — | R 809 | 42d | — | — | 1 | R 809 PFS proxy | 1 |
FULV/FULV and RT Partial | — | — | — | — | — | — | — | — |
Radiation therapy N/A - radiation | — | — | 49d | — | ~9.2 mo | — | — | 1 |
5 of 5 regimens shown